Lupin Ltd

Lupin Posted Sales Growth of 22 % At Rs 4237 Cr in Q1 FY22

Lupin -- the sixth largest company in Indian pharmaceutical market -- said its gross profit was buoyed by the USD 50 million received from Boehringer Ingelheim for achieving key milestonesfor its novel MEK inhibitor compound collaboration.